Pain in Inflammatory Joint Diseases

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorDiakonhjemmet Hospital

About this trial

Our primary objective is to better understand the etiology and consequences of chronic paint by using an explorative approach to identify phenotypes and endotypes of patients with inflammatory joint diseases, with a special focus on central sensitization and cognitive functioning as a key element in chronic pain. We will also examine the risk factors and clinical impact of these factors on pain, disease activity and treatment effects in a longitudinal study of patients with inflammatory joint disesases.

Eligibility criteria

Qualifiers

All patients who initiate or switch biological or targeted synthetic DMARDs

Disqualifiers

None

Trial design

Treatments tested in this trial

  • Biological or targeted synthetic DMARD

Treatment groups

350 Participants
are divided into 1 treatment group

Sponsors and collaborators

Diakonhjemmet Hospital

Lead sponsor

University of Oslo

Collaborator